E-LIB Suche - Ergebnisse für: Shukuya, Takehito

1

Detection of a co-mutation in the epidermal growth factor r..:

Yoshida, Hiroshi ; Ozasa, Hiroaki ; Hashimoto, Kentaro...
Current Problems in Cancer: Case Reports. 14 (2024) - p. 100286 , 2024

Link: https://doi.org/10.1016/..

2

A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Na..:

Nakamichi, Shinji ; Kubota, Kaoru ; Matsuyama, Kotone...
Clinical Lung Cancer. 25 (2024) 1 - p. 85-90 , 2024

Link: https://doi.org/10.1016/..

3

Extrapleural air secondary to idiopathic pulmonary fibrosis..:

Nagata, Yuichi ; Watanabe, Takayasu ; Tanabe, Yuki...
Respirology Case Reports. 12 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

4

Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinas..:

Okuma, Yusuke ; Shintani, Yasushi ; Sekine, Ikuo...
Clinical Lung Cancer. 25 (2024) 4 - p. 336-346.e2 , 2024

Link: https://doi.org/10.1016/..

5

Prediction of prognosis in lung cancer using machine learni..:

Fujimoto, Daichi ; Hayashi, Hidetoshi ; Murotani, Kenta...
Lung Cancer. 194 (2024) - p. 107896 , 2024

Link: https://doi.org/10.1016/..

6

Trophoblast Cell Surface Antigen 2 Expression in Thymic Car..:

Kurokawa, Kana ; Asao, Tetsuhiko ; Hayashi, Takuo...
JTO Clinical and Research Reports. 5 (2024) 7 - p. 100693 , 2024

Link: https://doi.org/10.1016/..

7

Risk and survival of patients with non-small cell lung canc..:

Asao, Tetsuhiko ; Shukuya, Takehito ; Uemura, Kohei...
Lung Cancer. 194 (2024) - p. 107894 , 2024

Link: https://doi.org/10.1016/..

8

Lymphangioleiomyomatosis as a potent lung cancer risk facto..:

Torasawa, Masahiro ; Shukuya, Takehito ; Uemura, Kohei...
Respirology. , 2024

Link: https://doi.org/10.1111/..

9

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Bloc..:

Xu, Shiting ; Miura, Keita ; Shukuya, Takehito...
Cancers. 15 (2023) 4 - p. 1170 , 2023

Link: https://doi.org/10.3390/..

10

Study Design and Rationale for Marble Study: A Phase II Tri..:

Asao, Tetsuhiko ; Shukuya, Takehito ; Mimori, Tomoyasu...
Clinical Lung Cancer. 24 (2023) 7 - p. e247-e253 , 2023

Link: https://doi.org/10.1016/..

11

Real‐world therapeutic effectiveness of lorlatinib after al..:

Goto, Yasushi ; Shukuya, Takehito ; Murata, Ai...
Cancer Science. 114 (2023) 6 - p. 2560-2568 , 2023

Link: https://doi.org/10.1111/..

12

Health Care Resource Use Among Patients with Advanced Non–S..:

Goto, Yasushi ; Kawamura, Kodai ; Fukuhara, Tatsuro...
Current Therapeutic Research. 99 (2023) - p. 100712 , 2023

Link: https://doi.org/10.1016/..

13

A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-P..:

Miyanaga, Akihiko ; Asahina, Hajime ; Watanabe, Satoshi...
Clinical Lung Cancer. 24 (2023) 4 - p. 371-375 , 2023

Link: https://doi.org/10.1016/..

14

Improvement in Survival for Patients With Lung Cancer in Ta..:

Oezkan, Filiz ; Seweryn, Michal ; Shukuya, Takehito.
Journal of Thoracic Oncology. 18 (2023) 1 - p. 21-25 , 2023

Link: https://doi.org/10.1016/..

15

CALML5 is a novel diagnostic marker for differentiating thy..:

Kanamori, Koichiro ; Suina, Kentaro ; Shukuya, Takehito...
Thoracic Cancer. 14 (2023) 12 - p. 1089-1097 , 2023

Link: https://doi.org/10.1111/..